The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis
Authors:
- T. B. M. TilanusTTT. B. M. Tilanus
- J. T. GroothuisJGJ. T. Groothuis
- J. M. C. TenBroek-PastoorJTJ. M. C. TenBroek-Pastoor
- T. B. FeuthTFT. B. Feuth
- Y. F. HeijdraYHY. F. Heijdra
- J. P. L. SlendersJSJ. P. L. Slenders
- J. DoorduinJDJ. Doorduin
- B. G. Van EngelenBEB. G. Van Engelen
- M. J. KampelmacherMKM. J. Kampelmacher
- J. RaaphorstJRJ. Raaphorst
Open Access
- 25 July 2017
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 18 (1) , 1-10
Abstract
Non-invasive ventilation (NIV) improves survival and quality of life in amyotrophic lateral sclerosis (ALS) patients. The timing of referral to a home ventilation service (HVS), which is in part based on respiratory function tests, has shown room for improvement. It is currently unknown which respiratory function test predicts an appropriate timing of the initiation of NIV. We analysed, retrospectively, serial data of five respiratory function tests: forced vital capacity (FVC), peak cough flow (PCF), maximum inspiratory and expiratory pressure (MIP and MEP) and sniff nasal inspiratory pressure (SNIP) in patients with ALS. Patients who had had at least one assessment of respiratory function and one visit at the HVS, were included. Our aim was to detect the test with the highest predictive value for the need for elective NIV in the following 3 months. We analysed time curves, currently used cut-off values for referral, and respiratory function test results between ‘NIV indication’ and ‘no-NIV indication’ patients. One hundred ten patients with ALS were included of whom 87 received an NIV indication; 11.5% had one assessment before receiving an NIV indication, 88.5% had two or more assessments. The NIV indication was based on complaints of hypoventilation and/or proven (nocturnal) hypercapnia. The five respiratory function tests showed a descending trend during disease progression, where SNIP showed the greatest decline within the latest 3 months before NIV indication (mean = −22%). PCF at the time of referral to the HVS significantly discriminated between the groups ‘NIV-indication’ and ‘no NIV-indication yet’ patients at the first HVS visit: 259 (±92) vs. 348 (±137) L/min, p = 0.019. PCF and SNIP showed the best predictive characteristics in terms of sensitivity. SNIP showed the greatest decline prior to NIV indication and PCF significantly differentiated ‘NIV-indication’ from ‘no NIV-indication yet’ patients with ALS. Currently used cut-off values might be adjusted and other respiratory function tests such as SNIP and PCF may become part of routine care in patients with ALS in order to avoid non-timely initiation of (non-invasive) ventilation.Keywords
This publication has 35 references indexed in Scilit:
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task forceEuropean Journal of Neurology, 2011
- Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary resultsAmyotrophic Lateral Sclerosis, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Study of 962 patients indicates progressive muscular atrophy is a form of ALSNeurology, 2009
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)Neurology, 2009
- Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patientThorax, 2009
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Maximal values of sniff nasal inspiratory pressure in healthy subjects.Thorax, 1995
- Distribution of peak expiratory flow variability by age, gender and smoking habits in a random population sample aged 20-70 yrsEuropean Respiratory Journal, 1994
- Predicted normal values for maximal respiratory pressures in caucasian adults and children.Thorax, 1984